Melanoma in the brain
Authors:
- Geoffrey Thomas GibneyGGGeoffrey Thomas Gibney
- Peter A. ForsythPFPeter A. Forsyth
- Vernon K. SondakVSVernon K. Sondak
- 1 June 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 22 (3) , 177-183
Abstract
The development of brain metastases is a frequent occurrence in patients with disseminated melanoma and contributes to a disproportionate degree of morbidity and mortality. The prognosis is markedly reduced once a patient is diagnosed with central nervous system disease. Definitive therapeutic interventions with resection or stereotactic radiosurgery have improved outcomes and become standard approaches in the management of melanoma brain metastases. With the inclusion of whole-brain radiation in these interventions, there has been a reduction in local recurrences, but no improvement in the overall survival. Still, many patients are not candidates for surgery nor radiotherapy nor develop progressive central nervous system disease after definitive therapy. As new immune-based and targeted therapeutic agents are developed for the treatment of metastatic melanoma, understanding their activity in brain metastases is necessary for effective patient management. In this review, we discuss the biology of brain metastases in metastatic melanoma, current treatment approaches with surgery and radiotherapy, and future systemic therapeutic strategies.Keywords
This publication has 49 references indexed in Scilit:
- Cancer statistics, 2011CA: A Cancer Journal for Clinicians, 2011
- Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic MelanomaJournal of Clinical Oncology, 2011
- The role of the organ microenvironment in brain metastasisSeminars in Cancer Biology, 2011
- Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post‐brain metastases survivalCancer, 2010
- Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanomaCancer, 2010
- Determinants of survival in patients with brain metastases from cutaneous melanomaBritish Journal of Cancer, 2010
- Determinants of Outcome in Melanoma Patients With Cerebral MetastasesJournal of Clinical Oncology, 2004
- Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanomaCancer, 2002
- Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanomaJournal of Neurosurgery, 1998
- Cranial irradiation after surgical excision of brain metastases in melanoma patientsAnnals of Surgical Oncology, 1996